Fingerprint
Dive into the research topics of 'Phase 1 dose-escalation trial of tremelimumab plus sunitinib in patients with metastatic renal cell carcinoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase 1 dose-escalation trial of tremelimumab plus sunitinib in patients with metastatic renal cell carcinoma
Brian I. Rini, Mark Stein, Pat Shannon, Simantini Eddy, Allison Tyler, Joe J. Stephenson, Lorie Catlett, Bo Huang, Diane Healey, Michael Gordon
Research output: Contribution to journal › Article › peer-review
143
Scopus
citations